Sumit Bansal

I have bought Sterlite Technologies at 431 today. Target 10x in 5 years.

I have bought Black Box at 744.80 today. Target 10x in 5 years.

Crossed 2x !! Shaily Engineering Plastics has crossed 2x. x.com/NiftyGranmaste…

I have made following exits today as a part of the periodic portfolio rebalancing : JSW Energy at 569.65. Best Agrolife at 19.72.

x.com/NiftyGranmaste… Crossed 4x !! V-Marc has crossed 4x and completed a 4x journey from my entry level of 254.70. Today, in hindsight, this 4x journey feels laughably simple and effortless as the charts are now looking obvious and the narrative is now sounding intelligent. But none of these existed on 2nd August 2024, when I decided to buy V-Marc at 254.70. At that moment, V-Marc was neither an obvious nor an acceptable 4x story. V-Marc, at that time, was operating under the shadow of a recent regulatory action by SEBI. The company was shrouded in pessimism. Market sentiment towards it was intensely hostile and its leadership’s credibility was facing relentless skepticism and assault. As I remember 2nd August 2024 today, I can say that buying V-Marc publicly was one of the hardest decisions of my investing life ! At that time, no one on social media was ready to even talk about owning V-Marc. SEBI developments had created a shadow that was impossible to ignore. V-Marc was a stock surrounded by suspicion and it was a ticker universally quarantined and treated as untouchable ! At that time most people wanted the conversation to move to a “safer” stock the moment V-Marc’s name was mentioned. And when a stock is so radioactive and you decide to buy it, then you are no longer buying a balance sheet ! You are buying against opinion. You are buying against fear. You are buying against collective certainty. And that changes the psychological equation entirely. There is a hidden pressure that exists when you buy a stock carrying public negativity. You know that every future headline will be interpreted against you. You know that critics are waiting for confirmation that you were wrong. That pressure is invisible. But it is real. You start watching every move in the stock not with excitement, but with a quiet question at the back of your mind: “Did I misread this?” And publicly announcing such a buy amplifies it even further ! Private conviction is one thing. Public conviction is an altogether different ballgame. When you buy privately, capital is exposed. When you buy publicly, your reputation is exposed. Buying privately is easy. You answer only to yourself. But publicly announcing conviction in such a stock is different. Now your thinking becomes measurable. Your framework becomes measurable. Your judgment becomes measurable. You are no longer hiding behind silence. You are making a statement. And statements do have consequences. If the stock falls, critics remember. If the thesis fails, critics remember. If negativity intensifies, critics remember. Consensus mistakes are forgiven. But independent mistakes are rarely forgiven ! That is why most of the so‑called market experts always wait. They wait for institutional entry. They wait for price confirmation. They wait for public comfort. They wait for someone important to validate the story. But by the time validation arrives, the real opportunity is usually gone. Most investors, including professionals, are hard‑wired to herd; it is emotionally painful to go against the crowd, especially when the crowd appears unanimous. It feels safe to hide inside consensus and call it “prudence”. In situations like this, the “rational” choice for reputation is to stay away, stay silent or hide behind consensus, because consensus mistakes are collective in nature and are socially forgiven, while independent mistakes are punished. I chose the opposite. Buying V-Marc in that environment- and doing it publicly- meant deliberately walking away from the comfort of the herd. It meant accepting that, if things went wrong, I would not have the shield of “everyone else also owned it” to protect me; the mistake would be mine alone, visible and easy to attack. That asymmetry is exactly why very few people step forward before the narrative flips. To buy V-Marc in August 2024, a daredevil mindset was required—the willingness to look wrong, sound foolish and yet be early in a market that was going to celebrate you only in hindsight if you turn out to be right. And driven by that daredevil mindset, I pressed the buy button in August 2024. Nothing in my original work depended on any marquee investor validation as there was none on 2nd August 2024, the date of my entry. The numbers and the business and my conviction in them were enough for me to act and press the buy on V-Marc. And then, within a matter of days, my isolated and lonely conviction started converging with what serious money started seeing. And the absolute vindication arrived shortly thereafter. In a deeply surprising and full-circle moment, marquee investor Ashish Kacholia announced his entry into V-Marc right after I did. This full circle moment validated that independent thinking, done with rigor and integrity, can eventually find its place- and that serious work and well-reasoned conviction are always recognized, even if recognition arrives later. Today, in hindsight, I think that the decision to buy V-Marc in August 2024 did not require an exceptional IQ. It required a different set of muscles. Those muscles rarely grow in easy markets; they grow when you choose the uncomfortable path and stay with it. First, the ability to separate the business from the noise. To read the product history, the capacity, the client base and the financial trajectory, and hold that picture steady even as every headline and every tweet was screaming the opposite. You need the ability to sit with the raw data long enough for your own view to form, without running back to see “what others are saying”. Second, the ability to live with discomfort. When you buy something controversial, you don’t get the dopamine of social approval. Every dip feels louder. Every negative mention feels like a personal attack on your judgment. You need emotional stamina to not overreact, and not constantly seek validation from the market screen. Third, the ability to accept being wrong in public. Before buying, one has to be prepared for the worst‑case scenario: thesis fails, price collapses, and the same people who watched quietly on the way up become very loud on the way down. These are not textbook abilities. These are battle scars, built trade by trade, mistake by mistake, over years. Today the same 4x move is plainly visible on the chart. What is invisible is the journey: the doubt, the pushback, the psychological pressure and the choice to act before validation showed up. That is why V-Marc today is not just a multibagger in my portfolio; it is an exemplary milestone in my evolutionary journey. And it is the milestone that I would love to keep revisiting every time I need to choose between trusting my own work and following the crowd !

I have bought Kilburn Engineering at 591 on 26th November 2025 as a part of SMALLCAP Portfolio. Target 10x in 5 years.

I have exited Shakti Pumps at 688.54 on November 21, 2025 (bought at 415.60 on May 15, 2024) as a part of periodic portfolio rebalancing. Returns: 65.67%.

x.com/NiftyGranmaste… Crossed 2x !! Netweb Technologies has crossed 2x from my entry level. And this is just the starting point because Netweb isn't a stock that rallied. It's infrastructure that's materializing ! Rs 1,734 crore order [Q4 FY26-H1 FY27 execution], indigenous GPU servers, Blackwell architecture designed and manufactured in India, Defense-grade AI systems, ISRO's Vikram Sarabhai supercomputers [Rs 147.7 Cr order], IndiaAI Mission infrastructure- this isn't speculation—it's strategic infrastructure being deployed at national scale. While the world builds AI on imported silicon, Netweb is architecting India's digital sovereignty through indigenous GPU infrastructure, sovereign compute systems, and cutting-edge AI servers that will power India's ecosystem, capabilities, and technological ambitions for this decade and beyond. 𝗧𝗵𝗲 𝗺𝗮𝗿𝗸𝗲𝘁 𝘀𝗲𝗲𝘀 𝗮 𝘀𝘁𝗼𝗰𝗸 𝘁𝗵𝗮𝘁 𝗱𝗼𝘂𝗯𝗹𝗲𝗱. 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 𝘀𝗲𝗲 𝗜𝗻𝗱𝗶𝗮'𝘀 𝗔𝗜 𝗱𝗲𝗰𝗮𝗱𝗲 𝗯𝗲𝗶𝗻𝗴 𝗯𝘂𝗶𝗹𝘁 𝗶𝗻 𝗿𝗲𝗮𝗹-𝘁𝗶𝗺𝗲. Rs 1,734 Cr order (Q4 FY26-H1 FY27 execution), Rs 450 Cr follow-on (end FY26), Rs 4,142 Cr order book, Q1 FY26: 100% YoY PAT growth on 101.7% revenue acceleration, AI segment at 300% YoY growth- these aren't numbers—they're execution proof. When the next wave of orders lands and it will- when margin expansion inflects as AI mix scales, when capacity utilization hits 80%+, when international markets open—that's where broader market consensus would finally arrive. By then, conviction capital would have already compounded ! 𝗕𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗚𝗣𝗨 𝗿𝗮𝗶𝗹𝘀 𝗳𝗼𝗿 𝗜𝗻𝗱𝗶𝗮'𝘀 𝗔𝗜 𝗱𝗲𝗰𝗮𝗱𝗲 𝗶𝘀𝗻'𝘁 𝗽𝗼𝗲𝘁𝗿𝘆. 𝗜𝘁'𝘀 𝗮𝗿𝗶𝘁𝗵𝗺𝗲𝘁𝗶𝗰. And the math is just getting started ! When governments commit Rs 10,300 crore to sovereign compute and pick you as India's ONLY indigenous end-to-end HPC OEM with NVIDIA manufacturing partnership, that's not luck. That's structural moat. When national missions like IndiaAI Mission succeed— the execution enablers compound. That's not speculation. That's history: Infosys (IPO to 10,000x), HDFC Bank (post-housing boom), TCS (infrastructure enabler, 15-year compounder). The pattern repeats: infrastructure + policy + execution = compounding returns for patient capital. 𝗧𝗵𝗲 𝘀𝗺𝗮𝗿𝘁 𝗺𝗼𝗻𝗲𝘆 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘇𝗲𝘀 𝘁𝗵𝗶𝘀 𝗽𝗮𝘁𝘁𝗲𝗿𝗻. The smart money isn't still celebrating this 2x. It's still accumulating it—because smart money understands what most don't. Market is still pricing Netweb as just another stock which is India's AI infrastructure play ! India's AI revolution will 𝗻𝗼𝘁 run on foreign dependencies. It will run on indigenous architecture- on companies like Netweb, building the rails that power a nation's digital sovereignty. When national tech missions align with execution with a flawless delivery and margin expansion, the enabler stocks don't 2x. 𝗧𝗵𝗲𝘆 𝗰𝗼𝗺𝗽𝗼𝘂𝗻𝗱 𝗮𝗻𝗱 𝗸𝗲𝗲𝗽 𝗰𝗼𝗺𝗽𝗼𝘂𝗻𝗱𝗶𝗻𝗴 𝗳𝗼𝗿 𝗱𝗲𝗰𝗮𝗱𝗲𝘀.

I have exited Ganesh Housing at 823.96 on November 14, 2025 (bought on January 23, 2024 at 659.85) as a part of periodic portfolio rebalancing.

I have bought Vintage Coffee & Beverages today at 164.99 as a part of the SMALLCAP Portfolio. Target 10x in 5 years.

I have bought R&B Denims today at 123.81 as a part of the SMALLCAP Portfolio. Target 10x in 5 years.

I have made following exits today as a part of the periodic portfolio rebalancing : Jupiter Wagons at 315.95. Data Patterns (India) Ltd at 2622.10.

I have made following exits on 27th October 2025 as a part of periodic portfolio rebalancing : Sahyadri Industries at 256.95. Samrat Pharmachem at 289.22. Automotive Stampings & Assemblies Ltd at 528. Rathi Steel & Power at 24.90. Kirloskar Brothers at 1901.

I have bought Viviana Power Tech at 1610 today as a part of the SME Portfolio. Target 10x in 5 years.

I have bought Ashapura Minechem at 669.65 today. Target 10x in 5 years.

I have made following exits on 9th October 2025 as a part of periodic portfolio rebalancing : Vilas Transcore at 500.92. Vasa Denticity at 601.50. Taylormade Renewables at 183.80.

I have bought Madhya Bharat Agro Products at 428.14 today. Target 10x in 5 years.

I have exited Utssav CZ Gold Jewels at 169.50 on October 1, 2025 (bought on August 13, 2024 at 140.35) as a part of periodic portfolio rebalancing.

x.com/NiftyGranmaste… Jeena Sikho Lifecare has crossed 3x in just over 1 year. From my entry at 258.80 on 16 Aug 2024 (pre‑split 1294) to today’s 837, what began as a structural and strategic bet on India’s wellness revolution has matured into another validation of patience-backed conviction. Jeena Sikho Lifecare is yet another example of 𝗦𝗽𝗼𝘁𝘁𝗶𝗻𝗴 𝗦𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗮𝗹 𝗧𝗮𝗶𝗹𝘄𝗶𝗻𝗱𝘀 𝗕𝗲𝗳𝗼𝗿𝗲 𝗖𝗼𝗻𝘀𝗲𝗻𝘀𝘂𝘀. In August 2024, the consensus was still half‑asleep to the structural changes brewing in AYUSH. Post‑COVID Pharma chatter had faded. And the AYUSH sector was merely a polite murmur in the corner. Too “niche” for the big funds, too “slow” for the momentum chasers. But if you listened closely, you could hear the hum of something building — a 𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗮𝗹 𝘁𝗶𝗱𝗲 that would not be stopped and a 𝗱𝗲𝗰𝗮𝗱𝗮𝗹 𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗮𝗹 𝘀𝗵𝗶𝗳𝘁 that was underway. India was pivoting from reactive treatment to 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝘃𝗲 𝘄𝗲𝗹𝗹𝗻𝗲𝘀𝘀, as post pandemic awareness rewired consumer priorities. The Government policy was also aligning with heritage. India’s wellness revolution wasn’t a quarterly theme — it was a decadal structural shift. Most saw it as “alternative medicine.” I saw 𝗺𝗮𝗶𝗻𝘀𝘁𝗿𝗲𝗮𝗺 𝘄𝗲𝗹𝗹𝗻𝗲𝘀𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗺𝗮𝗸𝗶𝗻𝗴 — a 20‑year runway, not a 2‑year trade. This 2‑𝗱𝗲𝗰𝗮𝗱𝗲 𝘀𝗵𝗶𝗳𝘁 toward preventive healthcare was going to be an irreversible wave. And this wasn’t just about chasing a wave — this was more about finding a wave‑creator and identifying a superior business model. Jeena Sikho’s business model was 𝗰𝗮𝗽𝗶𝘁𝗮𝗹‑𝗹𝗶𝗴𝗵𝘁, 𝗳𝗿𝗮𝗻𝗰𝗵𝗶𝘀𝗲‑𝗱𝗿𝗶𝘃𝗲𝗻, 𝗮𝗻𝗱 𝗲𝘅𝗽𝗼𝗻𝗲𝗻𝘁𝗶𝗮𝗹𝗹𝘆 𝘀𝗰𝗮𝗹𝗮𝗯𝗹𝗲. While others poured crores into concrete and steel, Jeena Sikho scaled through partnerships, keeping ROCE above 70% and debt at zero. • Setup cost: 2.5–3.5 lakh per bed vs 15–25 lakh industry norm. • 53 of 111 facilities run by franchisees. • Payback periods under 6 months for smaller hospitals. This wasn’t just a healthcare company. It was a 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝘄𝗶𝘁𝗵 𝗻𝗲𝘁𝘄𝗼𝗿𝗸 𝗲𝗳𝗳𝗲𝗰𝘁𝘀 ! By August 2024, Jeena Sikho had: • NABH accreditations at scale with 24 NABH accredited facilities (~12% of India’s accredited Panchakarma centres). • CGHS empanelment and insurance coverage — rare in this niche segment. • A track record of consistent reinvesting into brand, process, and training. The story was obvious — but only for those who were looking in the right place. Brokerage reports didn’t capture it. Quarterly screeners didn’t flag it. But operational metrics, patient throughput, and franchisee economics- all were telling a different story ! This was a team that could scale without losing soul ! Bridging five‑thousand years of Ayurvedic wisdom with modern delivery wasn’t a line in excel valuation models — it lived in the operational metrics you only see after you do the 𝗱𝗲𝗲𝗽 𝘄𝗼𝗿𝗸. Product development, quality control, supply chain reliability, clinical validation and brand trust were the real inputs. Those are the knobs you turn to move from idea to repeatable revenue, and they’re invisible to anyone who skims quarterly slides. Jeena Sikho’s mirrored 𝗡𝗲𝘄 𝗜𝗻𝗱𝗶𝗮’𝘀 𝗰𝗼𝗻𝘀𝘂𝗺𝗽𝘁𝗶𝗼𝗻 𝘂𝗽𝗴𝗿𝗮𝗱𝗲: rising disposable incomes, health consciousness as a lifestyle choice, trust in indigenous brands and preference for natural cures over the synthetic. Today, Jeena Sikho becoming 3x is not just a healthcare play. It is a 𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗮𝗹 𝘀𝗵𝗶𝗳𝘁 identified at its right time and monetised ! This monetisation which is the visible today is the outcome of the process and art of weighing structural tides against business 𝗺𝗼𝗮𝘁, of matching patience with the right vessel rooted in conviction. Conviction is built in silence, far from headlines and far from heat, where you sit with the work and you sit with yourself. You test the thesis, you test your nerve and you wait for alignment. And I don’t share these milestones to 𝗽𝗼𝗹𝗶𝘀𝗵 my trophy — I share them to sharpen my blades. My every post is a timestamped ledger- a public ledger of how conviction is built before the crowd arrives. I write to remember — what I saw and why I acted, and what held in the storm when the screens were quiet. Documenting the journey creates accountability; Accountability sharpens the edge. The ledger teaches, and the ledger forgives nothing ! Compounding is slow at first; signals are faint while noise is loud, and the middle feels boring — which is exactly where you win. In Investing, let's think banyan, not bamboo — roots first, canopy later. A banyan spends years strengthening its foundation before its canopy begins to offer shade. Choose the banyan’s deep, anchoring roots over the bamboo’s quick, fragile rise if you want to build for permanence, not just for pace. Lay a deep, fundamental base before chasing rapid growth. When the market’s heavy rains arrive, those roots will only get deeper and stronger and not get washed away. Jeena Sikho was that banyan tree seed, planted in patience, compounding underground and its canopy is offering shade today. Jeena Sikho is proof that clarity before consensus and courage before comfort still compounds in public. Let's celebrate this milestone. And I am not closing a chapter; I am renewing a vow to raise the bar again and let the ledger speak for itself again !

x.com/NiftyGranmaste… Crossed 4x !! 4x in 18 months — ASM Technologies just etched its name in the tape ! From my entry at 999 on February 26, 2024 to a high of 4199.95 on Sep 11, 2025. Compounding doesn’t always need decades- it just needs the right story told at the right time ! Holders call it conviction. Non‑holders call it fleeting luck. And the tape calls it another chapter in the legendary investing textbook of @NiftyGranmaster Those who bought early were the visionaries. Those who came later are the optimists. And those who stayed out are going to become the storytellers !